兄弟科技(002562.SZ):擬投建年產13000噸維生素B3、3000噸香料及中間體建設項目
格隆匯4月19日丨兄弟科技(002562.SZ)公佈,公司於2020年4月16日召開公司第四屆董事會第三十次會議,審議通過了《關於投資新建年產13000噸維生素B3、3000噸香料及中間體建設項目的議案》。
項目擬新建年產8000噸煙酰胺、年產5000噸煙酸、年產3000噸香料(主要包括100噸/年二氫月桂烯醇、2000噸/年松油等)生產裝置及其配套設施,新增建築面積約56770平方米。項目估算總投資2.9億元,項目資金由公司自籌。
維生素B3是公司已有的重點發展產品之一,該項目的實施將通過維生素B3的技術創新,優化公司維生素B3的工藝技術,提升產品的綜合競爭力,並提高維生素B3在化粧品等高端市場的佔有率。
以松節油為基礎原料的香料產品是公司未來發展的重要方向之一,其中主要產品有二氫月桂烯醇、松油等。通過該項目的實施,可以加快公司進入松節油深加工領域的速度,為公司後續松節油深加工項目的發展奠定基礎。
該項目的實施將顯著提升公司維生素B3的市場競爭力,同時為公司未來松節油深加工項目的戰略發展奠定堅實的基礎,對公司未來的發展有着積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.